
Please try another search
Jenburkt Pharmaceuticals Limited researches and develops, manufactures, and markets pharmaceutical and healthcare products in India. The company offers products in various therapeutic areas, such as pain management, analgesic and anti-pyretics, muscle relaxants, nutraceuticals, neuropathic pain, anti-arthritic, anti-infectives, antifungals, antiulcerants/antacids, aphrodisiacs, antimalarials, anthelmintics, cough and cold, and anti- diabetics, as well as consumer products. It offers its products under the Allerzine, CartiSafe Forte, Eberjen, ECOPROT, Frendacid, Fundu, Glajen-E, GLUCOTROL, HYBRITA, Jenflam, La-Viril, LUMA, Lubtriben, Metmin, Nervega-75, Nervijen P, Nervijen, NOCAL, Numox-625, OJEN, ORNEL, Oxicojen, PANTAZOLE, PIRITEXYL, POWERDOL, Powergesic, Rabera, Topcal-M, Trapidol-D, TREGA, TRIBEN, ZENGLOBIN, ZIX, Zix-MR, Zix-PG 200/75, Zydol Suspension, and Zixa brand names. It serves its products through stockists, doctors, pharmacies, chemists, large government, semi-government institutions, missionary hospitals, and public sector enterprises. It exports its products. Jenburkt Pharmaceuticals Limited was incorporated in 1985 and is based in Mumbai, India.
Name | Age | Since | Title |
---|---|---|---|
Ashish Uttam Bhuta | 52 | 2007 | Chairman & MD |
Hina Ravindra Mehta | 61 | 2020 | Non-Executive & Independent Director |
Sumit Ajaybhai Thakkar | 41 | 2023 | Non-Executive & Independent Director |
Pankaj Arun Dantwala | 66 | 2024 | Non-Executive & Independent Director |
Krishnan Subharaman | 65 | 2024 | Non-Executive & Independent Director |
Dilip Harkishandas Bhuta | 73 | 2013 | CFO & Whole Time Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review